CVS customer seeks dismissal of recent drug prices lawsuit
A CVS customer wants to end a short-lived, federal lawsuit that hit the drugstore chain in a sensitive area: The prices it charges for prescriptions.
Aug 30, 2017
0
0
A CVS customer wants to end a short-lived, federal lawsuit that hit the drugstore chain in a sensitive area: The prices it charges for prescriptions.
Aug 30, 2017
0
0
Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another ...
Jul 26, 2017
0
0
Georgia's highest court on Monday rejected a challenge to a state law banning most abortions after 20 weeks, saying the courts are barred from considering lawsuits against the state without the state's consent.
Jun 19, 2017
0
0
(HealthDay)—A court ruling allowing a civil rights lawsuit against a medical examiner may have serious consequences for physicians in public service, according to a report published by the American Medical Association.
Jun 4, 2017
0
0
The maker of the pain medication OxyContin has asked a federal judge in Seattle to throw out a Washington city's lawsuit that seeks to hold the drugmaker responsible for allowing its pills to flood the black market and into ...
Mar 21, 2017
1
0
A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.
Jan 9, 2017
0
1
A St. Louis jury on Thursday awarded a California woman more than $70 million in her lawsuit alleging that years of using Johnson & Johnson's baby powder caused her cancer, the latest case raising concerns about the health ...
Oct 28, 2016
0
0
Two lawsuits ended in jury verdicts worth $127 million. Two others were tossed out by a judge who said there wasn't reliable evidence that the talc in Johnson & Johnson's iconic baby powder causes ovarian cancer. So who's ...
Sep 26, 2016
0
29
One of the companies alleged to have conspired to keep generic versions of a popular opioid treatment off the market says the antitrust lawsuit has no merit.
Sep 23, 2016
0
0
Juno Therapeutics and its CEO, Hans E. Bishop, are being named in a lawsuit over whether the biotechnology company misled investors about the death of a patient in a key study involving its drug intended to treat leukemia.
Jul 13, 2016
0
0